Mendelian randomization of blood lipids for coronary heart disease
University of Pennsylvania · University College London · +35 more institutions
Abstract
AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P
Citation impact
- FWCI
- 38.84
- Percentile
- 100%
- References
- 36
Authors
68- MVMichael V. HolmesCorresponding
University of Pennsylvania, University College London
- FWFolkert W. Asselbergs
University College London, University Medical Center Utrecht, Netherlands Heart Institute
- TPTom Palmer
University of Warwick
- FDFotios Drenos
University of Bristol, University College London
- MBMatthew B. Lanktree
McMaster University
Topics & keywords
- Mendelian randomization
- Single-nucleotide polymorphism
- Medicine
- Allele
- Internal medicine
- Cholesterol
- Genetics
- Gastroenterology
- Good health and well-being
Funding
- UDU.S. Department of Health and Human ServicesAwards: 42107-26, 32118-32119, 32115, 32111-13, 44221, 32108-9, 32122, 24152, 32105-6, 42129-32, 32100-2
- AAstraZeneca
- GGlaxoSmithKline
- QMQueen Mary University of London
- LSLondon School of Hygiene and Tropical Medicine
- WTWellcome TrustAwards: 090532, 090532/Z/09/Z, 090532/Z/09/
- GOGovernment of the United Kingdom
- NINational Institute for Health and Care Research
- BHBritish Heart FoundationAwards: LSHM-CT-2007-037273, G0802432, 090532/Z/09/Z, BHF RG 08/008, PG/07/133/24260, RG/07/005, RG/10/12/28456, RG/07/005/23633, PG/07/131/24254
- RCResearch Councils UK
- UCUniversity College London
- ECEuropean CommissionAward: LSHM-CT-2007-037273
- RTRosetrees Trust
- UOUniversity of Bristol
- EFEuropean Foundation for the Study of Diabetes
- DFDeutsche ForschungsgemeinschaftAward: TH-784/2-2
- ZZonMw
- AOAcademy of Finland
- BFBundesministerium für Bildung und ForschungAward: 01GS0834
- HHjärt-LungfondenAward: RG/10/12/28456
- KIKarolinska Institutet
- KOKnut och Alice Wallenbergs Stiftelse
- SLStockholms Läns LandstingAward: 560183
- UIUniversitetet i Oslo
- UUUniversität Ulm
- NINational Institutes of HealthAwards: 32122, NHLBI 33014, 32111-13, 32118-32119, 44221, 32115, 42107-26, 42129-32, 32108-9, 32100-2, 23633, 24152, 32105-6
- MRMedical Research CouncilAwards: MR/K013351/1, MR/K006584/1, RG/10/12/28456, MR/L01629X/1, MR/K006215/1, WC1E 6BT, G0802432
- EAEconomic and Social Research CouncilAward: ES/J023299/1
- WCWorld Cancer Research Fund
- ANAgentschap NLAwards: grant IGE05012, IGE05012
- SASahlgrenska Akademin
- MZMünchner Zentrum für Gesundheitswissenschaften
- NINational Institute on AgingAwards: RG/10/12/28456, R01AG1764406S1
- NHNational Heart, Lung, and Blood InstituteAwards: 33014, 32100-2, 32118, 32118-32119, 42129-32, 32119, 24152, RG/10/12/28456, 32111-13, 32115, 32105-6, 42107-26, HL36310, 32108-9, 32122, 44221